ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

HAEGARDA
Hereditary angioedema
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

HAEGARDA Rx

Generic Name and Formulations:
C1 esterase inhibitor (human) 2000 IU, 3000 IU; lyophilized pwd for SC inj after reconstitution; preservative-free.

Company:
CSL Behring, LLC

Therapeutic Use:

Indications for HAEGARDA:

Routine prophylaxis to prevent hereditary angioedema (HAE) attacks in adolescent and adult patients.

Adults and Children:

Rotate inj sites. Give by SC inj (eg, abdominal area, other SC sites). 60 IU/kg twice weekly (every 3 or 4 days).

Warnings/Precautions:

Discontinue and treat if severe hypersensitivity reactions occur. Have epinephrine inj available. Risk of thromboembolism events. Contains human plasma; monitor for possible infection transmission (eg, viruses, Creutzfeldt-Jakob disease agent). Pregnancy. Nursing mothers.

Pharmacological Class:

C1 inhibitor.

Adverse Reactions:

Inj site reaction, hypersensitivity, nasopharyngitis, dizziness.

Note:

To report infections that may have been transmitted by Haegarda, call (866) 915-6958.

Generic Availability:

NO

How Supplied:

Single-use vial—1

Sign Up for Free e-Newsletters